TP53 and cutaneous melanoma: In consideration of a previous study demonstrating that TP53 mutation is involved in the carcinogenesis in cutaneous melanoma [20], we further detected the correlation between TP53 mutation and clinical outcomes in the patients with skin melanoma (n = 92).